Unitree's 53% drawdown stops at 3.4 times its IPO price
The 460% pop on debut day has been undone almost exactly, leaving the market paying about 125 times Unitree's 2025 revenue and more than 350 times its adjusted earnings, a valuation that prices Unitree's growth story, with earnings barely factoring in.
The Investor · Invest desk
What happened
- Unitree's Shanghai-listed shares sit about 53% below their first-day high of 1,100 yuan and about 39% below the 845-yuan close on their Aug. 19 2026 debut.
- The fall has taken roughly $20 billion of market value out of the stock since the debut close and about $35 billion from the peak, which had implied nearly 445 billion yuan.
- Unitree's 2025 revenue reached 1.70 billion yuan, with humanoids contributing 868 million yuan, or 51.78% of the total, on more than 5,500 units shipped in the year.
- The Information reported that the China Securities Regulatory Commission has informally told banks that humanoid listing candidates need recurring revenue, narrowing losses or real innovation; Reuters could not verify it.
Why it matters
- What it costs cost The writedown has been borne entirely by secondary buyers, since anyone allocated stock at the offer price is still up multiples while those who bought into the debut session are carrying the loss.
- What it limits constraint Holding here is a bet on compounding: the adjusted profit implied by the price is small enough to be a rounding error against the market value, so earnings are not what buyers are paying for.
- Who's exposed exposure With industrial work a sliver of sales and dozens of state co-funded training centres among the buyers, Unitree's top line depends on annual budget approvals, not on factory payback maths.
- What it sets up precedent A tighter informal listing bar in Shanghai pushes loss-making humanoid developers toward SPACs and private rounds, which is the route Agility has already taken.
Next story · Invest · 15h ago
Hong Kong opens Embodied AI hub where mainland robot makers can train for international scenariosConfirmed2 publishers
The floor of this drawdown is instructive because it sits above anything a private buyer ever paid. Unitree priced its Shanghai offering at 150.80 yuan a share, a valuation near 61 billion yuan, itself about 45% above the roughly 42 billion yuan the company had been targeting before the book opened [8][20], and Wednesday's close is 3.4 times that offer price [19]. The first day's 460% gain took the stock to about 7.3 times the offer [6][24], and what has come out of it since is that auction, or rather the part of the auction priced by people who could not get an allocation.
At roughly $30 billion the market pays about 125 times 2025 revenue and more than 350 times adjusted 2025 earnings [12], which backs out to adjusted profit near $86 million, about a third of sales [30]. That is a real margin on a small base. Guidance for the first half of 2026 is 1.052 billion to 1.128 billion yuan, growth of 36% to 45% [11]; double the midpoint, crudely, and the year is 2.18 billion yuan, about $306 million at the 7.13 yuan to the dollar implied by Wednesday's close, or 98 times [26][17]. Three more years of 40% compounding takes revenue to 4.66 billion yuan and the same market value to 46 times [27].
The composition of that revenue is the harder question. The Wall Street Journal puts industrial applications at less than 10% of 2025 revenue, so under 170 million yuan [18][28], and the Financial Times counts more than 90 humanoid training centres in China, many co-funded by local governments alongside robot manufacturers, buying humanoids to generate training data by teleoperation [4]. Average revenue per humanoid shipped works out at no more than about 158,000 yuan [21], which is a research budget line rather than a labour-replacement payback, and research budgets get re-approved annually.
Set against Agility Robotics, which opened its books through the Churchill Capital Corp XI SPAC, Unitree's 2025 revenue is roughly 142 times larger, and Agility lost about 78 dollars for every dollar it sold [22][23]. That gap is why the securities regulator's reported preference for recurring revenue and loss reduction, per The Information, echoed separately by the Wall Street Journal [13][14], works as much in Unitree's favor as against it: it builds a moat around the company at least as much as it disciplines the sector.
The branch points are visible. If the training centres are a one-time restock, second-half growth decelerates below the 36% floor of the first-half guide and 125 times trailing revenue does not survive it. Should they instead seed repeatable industrial orders, the more than 40% of 2025 revenue booked overseas [18] argues the demand is not purely a domestic subsidy artefact, and 46 times in 2028 is arguable for a maker that, unlike many Western competitors, is not pre-revenue [16]. A listing bar that holds keeps comparables scarce either way. The view here is that the repricing removed the debut premium and left the composition question untouched, so the number deciding the next 50% in either direction is the industrial share of revenue. An industrial share climbing well past 10% in the 2026 accounts, with growth intact, would break that read.
What to watch
- Whether Unitree's 2026 accounts show the industrial share of revenue rising above the sub-10% figure the Wall Street Journal reported for 2025.
- Whether the China Securities Regulatory Commission's informal listing bar is confirmed on the record, and which humanoid candidate becomes the test case.
- Whether the Agility Robotics deal with Churchill Capital Corp XI closes, and at what value against $1.78 million of net sales.
Information, not investment advice. This story is general information about companies and markets, drawn from cited reporting. It is not a recommendation to buy, sell or hold any security; check the cited sources before acting.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence60
- Adoption40
- Hype gap+35
- Incentives55
- Confidence58
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Unitree Robotics, based in Hangzhou, trades on the Shanghai Stock Exchange under ticker 688836 and closed Wednesday at 513.93 yuan ($72.10).
- [2]
Unitree's shares are down about 39% from their 845-yuan closing price on debut on Aug. 19 2026 and about 53% below the first-day high of 1,100 yuan.
- [3]
The decline has erased roughly $20 billion of market value from the first-day close and about $35 billion from the peak.
- [4]
The Financial Times has reported that China has established more than 90 humanoid training centres, many co-funded by local governments and robot manufacturers, which buy humanoids and use them to generate training data, often through teleoperation.
- [5]
Unitree's IPO price was 150.80 yuan per share, and the shares remain more than three times that level.
- [6]
Unitree raised about 6.1 billion yuan ($900 million) in its IPO and its shares rose 460% on the first day of trading.
- [7]
At its intraday high of 1,100 yuan the stock implied a valuation of nearly 445 billion yuan, roughly $66 billion, more than 250 times 2025 revenue.
- [8]
Before the IPO Unitree had targeted a valuation of roughly 42 billion yuan ($6.2 billion); it priced at 150.80 yuan, valuing the company at about 61 billion yuan ($9 billion).
- [9]
Unitree generated 1.70 billion yuan ($252 million) of revenue in 2025, up from 392.77 million yuan in 2024.
- [10]
Humanoid robots produced 868 million yuan of 2025 revenue, 51.78% of the total, on more than 5,500 humanoids shipped during the year.
- [11]
Unitree projected first-half 2026 revenue of 1.052 billion to 1.128 billion yuan, year-over-year growth of roughly 36% to 45%.
- [12]
At Wednesday's close Unitree was worth roughly $30 billion, about 125 times its 2025 revenue and more than 350 times its adjusted 2025 earnings.
- [13]
According to The Information, the China Securities Regulatory Commission has informally told some banks and companies that prospective humanoid listings should show recurring revenue, progress toward reducing losses or significant technological innovation; Reuters could not independently verify the report and Chinese financial regulators have not commented.
- [14]
The Wall Street Journal separately reported that Chinese regulators have informally signalled that humanoid companies seeking to list should demonstrate stronger financials, revenue potential and genuine technological innovation.
- [15]
Agility Robotics' S-4 filing for its proposed SPAC with Churchill Capital Corp XI shows $1.78 million of 2025 net sales, a $140.2 million operating loss, a $138.1 million net loss and about $91.6 million of R&D spending.
- [16]
Unlike many of its Western humanoid competitors, Unitree is not a pre-revenue startup; it sells humanoids, quadrupeds and components.
- [17]
Wednesday's quote of 513.93 yuan equal to $72.10 implies an exchange rate of about 7.13 yuan to the dollar.
- [18]
The Wall Street Journal said less than 10% of Unitree's 2025 revenue came from industrial applications, and more than 40% of total 2025 revenue came from overseas, leaving roughly 60% domestic.
- [19]
Wednesday's close of 513.93 yuan is 3.41 times the 150.80-yuan IPO price.
- [20]
The 61 billion yuan valuation set at pricing was about 45% above the roughly 42 billion yuan Unitree had targeted before the offering.
- [21]
868 million yuan of humanoid revenue over more than 5,500 units shipped is average revenue per humanoid of no more than about 158,000 yuan.
- [22]
Unitree's 2025 revenue of $252 million is about 142 times Agility Robotics' $1.78 million of 2025 net sales.
- [23]
Agility Robotics' $138.1 million 2025 net loss is about 78 times its $1.78 million of net sales.
- [24]
The 1,100-yuan first-day high was about 7.3 times the 150.80-yuan offer price.
- [25]
Unitree's 2025 revenue of 1.70 billion yuan was 4.3 times its 392.77 million yuan of 2024 revenue.
- [26]
Doubling the midpoint of Unitree's first-half 2026 guidance gives full-year revenue of about 2.18 billion yuan, roughly $306 million, or about 98 times a $30 billion market value.
- [27]
Three more years of 40% revenue growth from 2025's 1.70 billion yuan gives 4.66 billion yuan, about $654 million, leaving a $30 billion market value at roughly 46 times revenue.
- [28]
Less than 10% of 1.70 billion yuan of 2025 revenue means under 170 million yuan came from industrial applications.
- [29]
The Robot Report's reading is that the decline does not necessarily mean investors have lost faith in Unitree, and suggests the market may be pulling back from the initial valuation.
- [30]
A $30 billion market value at more than 350 times adjusted 2025 earnings implies adjusted earnings near $86 million, roughly a third of $252 million of 2025 revenue.
Sources
2 independent publishers whose own reporting we read for this story.
- cryptopolitan.comUnitree's post-IPO plunge hints at potential unraveling of China's humanoid robots market
1 article · September 10, 2026
- Unitree shares down 53% from IPO debut
therobotreport.com
1 article · September 9, 2026
Topics and entities
Topics
- Humanoid Robots
- China listing regulation
Entities
- Churchill Capital Corp XI
- China Securities Regulatory Commission
- Unitree Robotics
- Shanghai STAR Market
- Agility Robotics